XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows provided by operating activities:    
Net income (loss) $ 405 $ (527)
Adjustments to reconcile net income (loss) to net cash from operating activities:    
Depreciation and amortization 166 182
Accretion of financing instruments and other non cash interest 32 52
Stock based compensation 8
Change in deferred tax assets 12 247
Impairment on investment in iBio, Inc. 251
Change in fair value of derivative liabilities (9) (67)
Gain on sale of fixed assets (3)
Changes in operating assets and liabilities:    
Accounts receivable (721) (575)
Inventories (3,794) (413)
Other current assets (47) (1)
Operating lease right of use assets 224
Security deposits and other assets (4) (19)
Accounts payable 2,989 1,379
Accrued expenses and other liabilities 58 126
Operating lease liabilities (225)
Net cash (used in) provided by operating activities (914) 640
Cash flows from investing activities:    
Purchase of property and equipment (287) (210)
Cash contribution in AgroSport LLC (7)
Cash proceeds from sale of equipment 4
Net cash used in investing activities (294) (206)
Cash flows from financing activities:    
Advances under revolving credit facility 22,899 19,673
Proceeds from sales/lease back of equipment 143
Proceeds from exercise of employee stock options 24
Repayments of advances under revolving credit facility (21,467) (19,559)
Repayments under term note payables (330) (669)
Repayments under capitalized lease obligations (101) (100)
Net cash provided by (used in) financing activities 1,025 (512)
Net decrease in cash (183) (78)
Cash at beginning of period 228 132
Cash at end of period 45 54
Supplemental disclosures of cash flow information:    
Interest paid 369 394
Income taxes paid $ 123 $ 109